Regeneron Pharmaceuticals, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US75886F1075
USD
772.03
-9.57 (-1.22%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
3,884.30
3,754.30
3,675.60
3,028.70
3,789.20
3,720.70
3,547.10
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,884.30
3,754.30
3,675.60
3,028.70
3,789.20
3,720.70
3,547.10
Raw Material Cost
729.60
658.30
665.30
591.20
691.50
612.80
600.90
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
461.30
438.30
449.40
451.60
0.00
407.80
422.50
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
12.20
19.30
3.60
8.70
10.50
13.80
14.80
Selling and Distribution Expenses
775.00
657.80
634.20
633.00
783.70
714.40
758.80
Other Expenses
100.76
88.07
83.36
74.02
126.14
72.82
64.20
Total Expenditure (Excl Depreciation)
2,985.70
2,654.40
2,586.10
2,424.70
2,747.10
2,477.00
2,439.00
Operating Profit (PBDIT) excl Other Income
898.6
1099.8999999999999
1089.5
604
1042.1
1243.7
1108.1
Other Income
514.30
545.20
193.00
182.30
191.50
192.80
180.80
Operating Profit (PBDIT)
1,557.90
1,791.80
1,417.60
913.20
1,344.50
1,550.20
1,395.00
Interest
12.20
19.30
3.60
8.70
10.50
13.80
14.80
Exceptional Items
-357.00
127.50
239.80
127.40
-249.50
78.30
368.60
Gross Profit (PBDT)
3,154.70
3,096.00
3,010.30
2,437.50
3,097.70
3,107.90
2,946.20
Depreciation
145.00
136.70
135.10
126.90
126.40
121.70
120.70
Profit Before Tax
1,043.70
1,763.30
1,518.70
905.00
958.10
1,493.00
1,628.10
Tax
199.10
303.30
127.10
96.30
40.40
152.40
195.80
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
844.60
1,460.00
1,391.60
808.70
917.70
1,340.60
1,432.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
844.60
1,460.00
1,391.60
808.70
917.70
1,340.60
1,432.30
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
844.60
1,460.00
1,391.60
808.70
917.70
1,340.60
1,432.30
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
31,256.90
30,957.80
29,938.90
29,387.60
29,353.60
29,325.90
28,205.80
Earnings per share (EPS)
7.86
13.62
12.81
7.27
8.06
11.54
12.41
Diluted Earnings per share
7.86
13.62
12.81
7.27
8.06
11.54
12.41
Operating Profit Margin (Excl OI)
23.13%
29.56%
29.64%
19.94%
27.09%
33.21%
30.83%
Gross Profit Margin
30.6%
50.61%
44.99%
34.07%
28.62%
43.4%
49.3%
PAT Margin
21.74%
38.89%
37.86%
26.7%
24.22%
36.03%
40.38%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 3.46% vs 2.14% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -42.15% vs 4.92% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -16.28% vs 1.80% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -36.79% vs 436.11% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Regeneron Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
3,884.30
3,227.10
657.20
20.37%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,884.30
3,227.10
657.20
20.37%
Raw Material Cost
729.60
466.00
263.60
56.57%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
461.30
0.00
461.30
Power Cost
0
0
0.00
Manufacturing Expenses
12.20
3.30
8.90
269.70%
Selling and Distribution Expenses
775.00
487.00
288.00
59.14%
Other Expenses
100.76
97.04
3.72
3.83%
Total Expenditure (Excl Depreciation)
2,985.70
1,926.70
1,059.00
54.96%
Operating Profit (PBDIT) excl Other Income
898.60
1,300.40
-401.80
-30.90%
Other Income
514.30
91.60
422.70
461.46%
Operating Profit (PBDIT)
1,557.90
1,445.10
112.80
7.81%
Interest
12.20
3.30
8.90
269.70%
Exceptional Items
-357.00
-57.70
-299.30
-518.72%
Gross Profit (PBDT)
3,154.70
2,761.10
393.60
14.26%
Depreciation
145.00
53.10
91.90
173.07%
Profit Before Tax
1,043.70
1,331.00
-287.30
-21.59%
Tax
199.10
139.90
59.20
42.32%
Provisions and contingencies
0
0
0.00
Profit After Tax
844.60
1,191.10
-346.50
-29.09%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
844.60
1,191.10
-346.50
-29.09%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
844.60
1,191.10
-346.50
-29.09%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
31,256.90
18,665.80
12,591.10
67.46%
Earnings per share (EPS)
7.86
4.65
3.21
69.03%
Diluted Earnings per share
7.86
4.65
3.21
69.03%
Operating Profit Margin (Excl OI)
23.13%
40.30%
0.00
-17.17%
Gross Profit Margin
30.60%
42.89%
0.00
-12.29%
PAT Margin
21.74%
36.91%
0.00
-15.17%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 388.43 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 3.46% vs 2.14% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 2.51% vs 10.33% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 84.46 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -42.15% vs 4.92% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -7.97% vs -20.86% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 104.36 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -16.28% vs 1.80% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -9.49% vs -0.92% in Dec 2024

Quarterly - Interest
Interest 1.22 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -36.79% vs 436.11% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 16.19% vs -42.62% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.13%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024